Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.72%, DAX30 +0.80%, CAC40 +0.67%

Apr 11 ,2025

  • Synopsis

    • European indices are set to open higher as Asian equities trade lower Friday with Japan down over 3% while Greater China markets have clawed back losses.

    • US equities were sharply lower in Thursday trading, though ended off worst levels. However, S&P and Nasdaq still on track for healthy weekly gains Wednesday's 9.5% rally for the S&P and 12% surge in the Nasdaq 100.

    • Stocks gave back some of their monster Wednesday rally, a good chunk of which was chalked up to oversold conditions/positioning/short covering. While Trump pause on higher reciprocal tariffs a key off-ramp, trade policy volatility expected to remain an overhang.

    • Among central banks updates: Friday sees, in central banks, Denmark central bank's Harr presentation at 8:00CET at the Univ. of Copenhagen. BOE's Saporta panellist at (time tbc) at the Delphi Economic Forum

    • Germany Mar final CPI, UK Feb industrial/manufacturing production, trade balance, construction output, Mar monthly GDP tracker - NIESR, Spain Mar final CPI, Switzerland Mar consumer confidence - SECO, Sweden Mar final CPI

    • In earnings: (ROS.AV) Rosenbauer International reports final FY earnings: EPS €4.00 vs FactSet €2.56. (VAR.NO) Vår Energi Trading Update: Q1 total production 272 kboepd vs FactSet 282.6; expects to reach the mid-point of FY production guidance. (MBTN.SW) Meyer Burger Technology reports preliminary FY revenue CHF69.9M vs FactSet CHF117.6M. (GXI.GR) Gerresheimer reports Q1 EPS €0.46 ex-items vs consensus €0.51; reaffirms guidance.

  • Politics/Macro/World News

    • EU could tax Big Tech if Trump trade talks fail, says von der Leyen (FT )

    • Treasuries Suddenly Trade Like Risky Assets in Warning to Trump (BBG )

    • EU brainstorms on how to brace for US tariffs as 90-day window opens (Reuters )

  • Top company news

    • Earnings/updates

      • NOVN.SW (Novartis) -- announces $23B investment in US-based infrastructure over 5 years; affirms confidence in FY25 guidance and sales growth outlook

      • LOGN.SW (Logitech International) -- reaffirms FY25 (ending Mar 2025) guidance; withdraws FY26 outlook citing tariff environment

      • GXI.GR (Gerresheimer) -- reports Q1 EPS €0.46 ex-items vs consensus €0.51; reaffirms guidance

      • MOWI.NO (Mowi) -- Q1 trading update: operational EBIT €214M vs FactSet €236.8M [11 est, €170-283M]

      • FRA.GR (Fraport) -- reports March Frankfurt Airport traffic statistics: passengers 4.6M, +0.3% y/y

      • FHZN.SW (Flughafen Zuerich) -- reports March traffic statistics

      • FLOW.NA (Flow Traders) -- reports March market statistics

      • BOSN.SW (Bossard Holding) -- reports Q1 revenue CHF283.9M vs FactSet CHF252.5M [2 est, CHF240-265M]

      • HAVAS.NA (Havas NV) -- reports Q1 revenue €649M vs FactSet €641.0M [1 est]; confirms FY25 guidance

    • M&A

      • NWH.UT.CN (Northwest Healthcare Properties REIT) -- Northwest Healthcare Properties Real Estate Investment Trust announces sale of its remaining stake in Assura PLC

      • 002075.CH (Jiangsu Shagang Co.) -- SC Capital reportedly weighing bid for Global Switch -- Reuters, citing sources

      • RIO.AU (Rio Tinto) -- commences compulsory acquisition of all remaining shares in ERA for A$0.002/share

      • RKT.LN (Reckitt Benckiser) -- Suitors for Reckitt Benckiser's homecare assets resist making binding offers amid tariff anxiety - Bloomberg

    • Healthcare

      • NOVN.SW (Novartis) -- planning $23B investment in US plants amid tariff threats - Reuters

      • GALE.SW (Galenica) -- announces approval of 4.5% increase in annual dividend to CHF2.30/sh

      • CRNA.NO (Circio Holding) -- signs research evaluation agreement with Lonza

    • Other

      • SAF.FP (Safran) -- and Ethiopian Airlines sign MoU for the provision of Z400 economy class seats for 8 Boeing 777-9 aircraft

      • BA.LN (BAE Systems) -- awarded $40.7M US Navy contract modification

      • RNO.FP (Renault) -- seeking to boost EV and hybrid sales as it emerges unscathed from industry turmoil caused by tariffs - FT

      • GLE.FP (Societe Generale) -- Societe Generale names William Connelly chairman starting May 2026

      • SBMO.NA (SBM Offshore) -- signs a $1.1B revolving credit facility

      • OCI.NA (OCI NV) -- OCI Global confirms it will pay an extraordinary cash distribution of $4.74 per share ($1.0B in total)

      • PRS.SM (Promotora de Informaciones) -- PRISA reports results of extraordinary conversion period of convertible notes issued April 2024

      • US DoJ reportedly planning to keep corporate monitorships at TD Bank (TD.CN) and Balfour Beatty (BBY.LN) in place -- Reuters, citing sources

  • Key rating changes

    • Upgrades

      • FRES.LN (Fresnillo) -- to add from hold at Peel Hunt

    • Downgrades

      • BP.LN (BP) -- to neutral from buy at UBS

      • COTY.FP (Coty) -- to neutral from outperform at BNP Paribas Exane

    • Initiations

      • ALCLS.FP (Cellectis SA) -- outperform at Oddo

  • Data

    • Nikkei (3.90%) to 33258.50

    • Hang Seng +1.27% to 20944.87

    • Shanghai Composite +0.39% to 3236.26

    • S&P futures +33.0 vs prior close of 5302.0

    • €-$ +0.0079 or +0.71% to 1.1280

    • $-¥ (0.82) or (0.57%) to 143.63

    • €-¥ +0.23 or +0.14% to 162.01

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE